Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease

Experimental and Molecular Pathology

Volumn 95, Issue 3, 2013, Pages 330-335

  Krautbauer, Sabrina ^a   Eisinger, Kristina ^a   Lupke, Madeleine ^a   Wanninger, Josef ^a   Ruemmele, Petra ^a   Hader, Yvonne ^a   Weiss, Thomas S ^a   Buechler, Christa ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Fatty liver; Gender; Hepatocyte; Superoxide dismutase

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; INTERLEUKIN 6; LEPTIN; LIPOPOLYSACCHARIDE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; OLEIC ACID; PALMITIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; SUPEROXIDE DISMUTASE;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; CLINICAL ARTICLE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DISEASE COURSE; FATTY LIVER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIPID DIET; LIVER; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; ADULT; ANIMAL; APOPTOSIS; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; CELL PROLIFERATION; COHORT ANALYSIS; COMPARATIVE STUDY; CYTOLOGY; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; YOUNG ADULT;

MUS; RODENTIA;

ADULT; AGED; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; COHORT STUDIES; FATTY LIVER; FEMALE; HEPATOCYTES; HUMANS; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 84887232935     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.10.003     Document Type: Article

References (39)

1. Bauer S., et al. Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients. Exp. Mol. Pathol. 2011, 90:101-106.
2. Brosnan M.J., Carkner R.D. Hepatic effects of a fructose diet in the stroke-prone spontaneously hypertensive rat. Am. J. Hypertens. 2008, 21:708-714.
3. Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 2004, 114:147-152.
4. Buechler C., Schaffler A. Does global gene expression analysis in type 2 diabetes provide an opportunity to identify highly promising drug targets?. Endocr. Metab. Immune Disord. Drug Targets 2007, 7:250-258.
5. Buechler C., et al. Adiponectin, a key adipokine in obesity related liver diseases. World J. Gastroenterol. 2011, 17:2801-2811.
6. Dougall W.C., Nick H.S. Manganese superoxide dismutase: a hepatic acute phase protein regulated by interleukin-6 and glucocorticoids. Endocrinology 1991, 129:2376-2384.
7. Fukai T., Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid. Redox Signal. 2011, 15:1583-1606.
8. Grasselli E., et al. Direct effects of iodothyronines on excess fat storage in rat hepatocytes. J. Hepatol. 2011, 54:1230-1236.
9. Hashimoto E., Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J. Gastroenterol. 2011, 46(Suppl. 1):63-69.
10. Herrera B., et al. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes. Free Radic. Biol. Med. 2004, 36:16-26.
11. Hill D.B., et al. Use of transfected liver cells to evaluate potential mechanisms of alcohol-induced liver injury. Alcohol. Clin. Exp. Res. 1998, 22:785-788.
12. Hsiao P.J., et al. Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet. BMC Mol. Biol. 2008, 9:82.
13. Huang C., et al. Testosterone-down-regulated Akt pathway during cardiac ischemia/reperfusion: a mechanism involving BAD, Bcl-2 and FOXO3a. J. Surg. Res. 2010, 164:e1-e11.
14. Ikegami Y., et al. Adiponectin upregulates ferritin heavy chain in skeletal muscle cells. Diabetes 2009, 58:61-70.
15. Jeschke M.G., et al. Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge. Mol. Med. 2008, 14:11-19.
16. Jou J., et al. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin. Liver Dis. 2008, 28:370-379.
17. Kim J., et al. Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice. A role for manganese superoxide dismutase. J. Biol. Chem. 2006, 281:20349-20356.
18. Kleiner D.E., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
19. Kohjima M., et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 2007, 20:351-358.
20. Krautbauer S., et al. Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Exp. Mol. Pathol. 2013, 95:199-205.
21. Larter C.Z., Yeh M.M. Animal models of NASH: getting both pathology and metabolic context right. J. Gastroenterol. Hepatol. 2008, 23:1635-1648.
22. Matsuzawa N., et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 2007, 46:1392-1403.
23. Midha M.K., et al. Extracting time-dependent obese-diabetic specific networks in hepatic proteome analysis. J. Proteome Res. 2012, 11:6030-6043.
24. Perlemuter G., et al. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int. 2005, 25:946-953.
25. Rolo A.P., et al. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 2012, 52:59-69.
26. Schmilovitz-Weiss H., et al. Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease - a historical prospective. Lipids Health Dis. 2013, 12:41.
27. Schneider C.A., et al. NIH Image to ImageJ: 25years of image analysis. Nat. Methods 2012, 9:671-675.
28. Takami Y., et al. Identification of a novel biomarker for oxidative stress induced by hydrogen peroxide in primary human hepatocytes using the 2-nitrobenzenesulfenyl chloride isotope labeling method. Hepatol. Res. 2010, 40:438-445.
29. Thasler W.E., et al. Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany. Cell Tissue Bank. 2003, 4:49-56.
30. Tilg H. The role of cytokines in non-alcoholic fatty liver disease. Dig. Dis. 2010, 28:179-185.
31. Tomizawa A., et al. Induction of gene expression in response to globular adiponectin in vascular endothelial cells. Life Sci. 2009, 85:457-461.
32. Tsuchiya H., et al. Iron state in association with retinoid metabolism in non-alcoholic fatty liver disease. Hepatol. Res. 2010, 40:1227-1238.
33. Valle A., et al. Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects. Liver Int. 2012, 32:951-961.
34. Videla L.A., et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. (Lond.) 2004, 106:261-268.
35. von Montfort C., et al. Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis. J. Hepatol. 2012, 57:852-859.
36. Wang J., et al. Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology 2009, 137:713-723.
37. Wang S., et al. Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo. Metabolism 2011, 60:1090-1099.
38. Wanninger J., et al. Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes. Biochim. Biophys. Acta 2011, 1811:626-633.
39. Zou Y., et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 2006, 79:1100-1107.